A Position of Strength

Pfizer is in excellent financial shape,CEO Jeff Kindler maintains.We've achieved significant cost savings-even beyond our goals,Mr.Kindler said.Our dividend is part of a long term strategy that will increase growth.Pfizer and Wyeth have very similar cultures;they should be a good fit,Jeff Kindler observed.Bernard Poussat,Wyeth Chairman and CEO,added that it's possible the deal will start a wave of pharmaceutical consolidation.This deal makes sense,Mr.Poussat agreed.